| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |